| 381 |
Maternal type 2 diabetes risk alleles and intrauterine growth. |
2010 |
| 382 |
Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen |
2010 |
| 383 |
Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen |
2010 |
| 384 |
ROLE OF ADIPONECTIN IN PATIENTS WITH NON-INSULIN
DEPENDENT DIABETES MELLITUS |
2010 |
| 385 |
ROLE OF ADIPONECTIN IN PATIENTS WITH NON-INSULIN
DEPENDENT DIABETES MELLITUS |
2010 |
| 386 |
ROLE OF ADIPONECTIN IN PATIENTS WITH NON-INSULIN
DEPENDENT DIABETES MELLITUS |
2010 |
| 387 |
Serum and tissue levels of VEGF, BFGF, Glutathione S Transferase , Nitric Oxide and Sialic Acid in Non-SCLC patients after treatment with Nimesolide (Cox-2 inhibitor) combined with chemotherapy. |
2010 |
| 388 |
Serum and tissue levels of VEGF, BFGF, Glutathione S Transferase , Nitric Oxide and Sialic Acid in Non-SCLC patients after treatment with Nimesolide (Cox-2 inhibitor) combined with chemotherapy. |
2010 |
| 389 |
Serum and tissue levels of VEGF, BFGF, Glutathione S Transferase , Nitric Oxide and Sialic Acid in Non-SCLC patients after treatment with Nimesolide (Cox-2 inhibitor) combined with chemotherapy. |
2010 |
| 390 |
The role of diabetes susceptibility genetic variants in preeclampsia |
2010 |
هل لديك سؤال ؟
